AcroMeta raises S$1.58M in rights cum warrants issue

What's the deal? AcroMeta Group LimitedDealroom has a profile for this one. Try Dealroom →, a Singapore-incorporated company listed on SGX Catalist, has completed a renounceable non-underwritten rights cum warrants issue, raising net proceeds of about S$1.58 million (≈$1,223,032). The company received valid subscriptions and excess applications for 105,854,172 rights shares with warrants — 39.94% of the total available.

What's the endgame? AcroMeta plans to deploy the proceeds towards general working capital needs and new initiatives. It has committed to periodic disclosure on how the funds are used.

How does it work? Unsubscribed provisional allotments were reallocated to satisfy excess applications, with priority given to rounding off odd lots for minority shareholders. Safeguards were included to prevent any unintended change in control.

The rights shares are expected to be allotted by mid-July 2026 and listed on SGX Catalist shortly after. The warrants will be detachable but not separately listed, offering additional potential equity funding over time.

The signal: The raise underscores AcroMeta's reliance on structured corporate actions for ongoing equity funding, against a modest current market capitalisation of S$11.93 million.

Read more: TipRanks

Image credit: Visualvalhalla